Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Invyncible
CoreAge Rx and Invyncible both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxInvyncible
Ranked #209 · Grade C
Best for: A reader who wants the option to start compounded and later move to a brand-name pen without switching providers, and who is willing to ask for a discount before paying the listed figure.
Visit InvyncibleThe verdict
CoreAge Rx edges out Invyncible on the Rx-Readiness Score, 95 to 53 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Invyncible is still a genuine option — the widest menu on this list, and a slip on its own page that is worth knowing about. Read live on 2026-08-26, Invyncible sells nine GLP-1 programs on one account: compounded semaglutide in five formulations from $192.50 a month, compounded tirzepatide in four from $210, an oral semaglutide capsule at $255.50 for readers who would rather not inject, and FDA-approved Wegovy and Zepbound at $1,750 and $1,540. That flexibility is genuine — you can start compounded and move to a brand-name pen without changing provider. Two things to hold in view. Every figure is displayed as a permanent sale against a higher reference price, and both program pages say "Looking for a discount? Chat, Email or Call us!", so the listed number is an opening position rather than a rate. And its Wegovy card describes the product as "the FDA-approved brand-name tirzepatide treatment" — Wegovy is semaglutide. It names its parent company, Nationwide Telemedicine, LLC, and a street address, but not the states it serves. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Invyncible |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 53/100 · C |
| Overall rank | #1 | #209 |
| Semaglutide | $99/mo | $192.50/mo |
| Tirzepatide | $149/mo | $210/mo |
| Coverage | All 50 states | Not publicly disclosed; confirmed during intake |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Invyncible
Ranked #209 · Grade C
What we like
- Nine GLP-1 programs on one account — five semaglutide formulations, four tirzepatide, plus both brand pens
- An oral semaglutide capsule route at $255.50 for readers who would rather not inject
- Names its parent company and a physical address rather than an anonymous storefront
The caveats
- No state-availability list — confirmed only during intake
- No published time-to-first-dose
- Every price is displayed as a permanent 'sale' against a higher reference figure that never appears to actually apply
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Invyncible against other providers on our shortlist.
Or browse the full comparison hub.